Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test
- PMID: 11151904
- DOI: 10.1111/j.1572-0241.2000.03381.x
Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test
Abstract
Objectives: Primary care physicians and internal medicine residents have poor understanding of colorectal cancer screening and the use of fecal occult blood tests. If acceptance and implementation of colorectal cancer screening is to improve, gastroenterologists may have to take a more leading role in the education of their primary care colleagues, physicians in training, and the general public. However, before this can be recommended, it is necessary to determine how closely gastroenterologists follow currently recommended guidelines and how they use fecal occult blood tests.
Methods: We mailed a two-page, structured questionnaire about colorectal cancer screening and use of fecal occult blood tests to 8000 randomly selected gastroenterologists in the United States.
Results: We received responses from 24% of the gastroenterologists. Almost all used fecal occult blood tests in the office setting, 86% on stool obtained at rectal examination. The test was frequently used for reasons other than colorectal cancer screening, and often without adequate patient instruction on dietary and medication restrictions. Of the respondents, 98% commenced screening at age < or = 50 yr, whereas 37% either continued screening into advanced age or never stopped. Annual fecal occult blood testing with flexible sigmoidoscopy every 5 yr was the screening strategy recommended by 71% of the respondents, whereas 25% recommended colonoscopy every 10 yr. However, 77% of the gastroenterologists chose colonoscopy for personal colorectal cancer screening.
Conclusions: Gastroenterologists usually give appropriate advice on colorectal cancer screening but often misuse fecal occult blood tests. This may produce excessively high false-positive screening rates, leading to unnecessary diagnostic testing without apparent benefit.
Similar articles
-
Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.Am J Gastroenterol. 2000 Aug;95(8):2068-73. doi: 10.1111/j.1572-0241.2000.02229.x. Am J Gastroenterol. 2000. PMID: 10950059
-
Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey.Am J Gastroenterol. 2000 Jun;95(6):1551-6. doi: 10.1111/j.1572-0241.2000.02093.x. Am J Gastroenterol. 2000. PMID: 10894595
-
Do gastroenterologists themselves follow the American Cancer Society recommendations for colorectal cancer screening?Am J Gastroenterol. 1994 Dec;89(12):2184-7. Am J Gastroenterol. 1994. PMID: 7977238
-
Colorectal cancer screening: present strategies and future prospects.Postgrad Med. 1996 Mar;99(3):253-64. Postgrad Med. 1996. PMID: 8637834 Review.
-
Colon cancer screening strategies.Curr Opin Gastroenterol. 2005 Jan;21(1):59-63. Curr Opin Gastroenterol. 2005. PMID: 15687886 Review.
Cited by
-
Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.Can Fam Physician. 2012 Sep;58(9):939-48. Can Fam Physician. 2012. PMID: 22972722 Free PMC article.
-
Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.Can J Gastroenterol. 2013 Dec;27(12):711-6. doi: 10.1155/2013/816305. Can J Gastroenterol. 2013. PMID: 24340316 Free PMC article.
-
Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.Can J Gastroenterol Hepatol. 2014 Sep;28(8):421-6. doi: 10.1155/2014/189652. Epub 2014 Jul 11. Can J Gastroenterol Hepatol. 2014. PMID: 25014182 Free PMC article.
-
Awareness of and adherence to cancer screening guidelines among health professionals in Japan.Cancer Sci. 2007 Aug;98(8):1241-7. doi: 10.1111/j.1349-7006.2007.00512.x. Epub 2007 May 30. Cancer Sci. 2007. PMID: 17537173 Free PMC article.
-
Prevalence of significant neoplasia in FOBT-positive patients on warfarin compared with those not on warfarin.Am J Gastroenterol. 2010 Sep;105(9):2030-4; quiz 1962, 2035. doi: 10.1038/ajg.2010.264. Epub 2010 Aug 3. Am J Gastroenterol. 2010. PMID: 20683445 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical